ICPerMed developed a study on "Challenges, Opportunities, and Facilitators in Implementing Personalised Medicine" that outlines strategies for integrating personalised medicine into healthcare systems, aiming to improve health outcomes and create sustainable healthcare systems through research, development, innovation, and implementation. It presents identified significant hurdles for personalised medicine implementation and offers actionable recommendations for stakeholders, including healthcare professionals, policy makers, patient organisations, and researchers.
Eight major facilitators were identified:
- Engaging relevant stakeholders in the implementation process of personalised medicine
- Collaboration between relevant stakeholders during the implementation process of personalised medicine
- Establishment of a national or regional common strategy
- Infrastructure needed during the implementation process of personalised medicine
- Education and training in personalised medicine
- Resource allocation during the implementation process of personalised medicine
- Regulations and legislations for personalised medicine approaches
- Ethical considerations
Methodology: The “Challenges, Opportunities and Facilitators in Implementing Personalised Medicine” document presents a review of challenges and the identification of facilitators for PM implementation in healthcare practices formulated as recommendations, both elaborated through dedicated interviews conducted with representatives of identified PM application examples, with the support of the ICPerMed Secretariat and under consultation of members of the ICPerMed working group “Personalised Medicine in Healthcare” as well as consultation of the ICPerMed Advisory Board.
The results of the study “Challenges, Opportunities and Facilitators in Implementing Personalised Medicine” can be downloaded:
